BACKGROUND: Long-term consequences of cancer treatments in young @entity1 , and especially fertility issues, are gaining attention as survival rates increase. @entity0 is the most frequent @entity5 in @entity1 of reproductive age. AIM: The purpose of this review is to describe serum anti-m  llerian hormone ( @entity248 ) level at diagnosis and its evolution during and after chemotherapy in @entity1 of reproductive age treated for @entity0 . Second, the impact of @entity6023 on @entity248 , the association between @entity248 and @entity2588 , and the comparison of @entity248 with other hormonal markers of ovarian reserve were studied. METHODS: A systematic PubMed search was conducted on all articles, published up to April 2016 and related to @entity248 in @entity1 suffering from @entity0 using the following key words: @entity248 , m  llerian-inhibiting substance, @entity2670 , @entity0 , gonadotoxicity, @entity2670 , @entity2588 , chemotherapy, and menopause. RESULTS: @entity248 levels rapidly fall down to undetectable levels in most @entity1 during chemotherapy and generally persist at very low levels in most @entity1 after the treatment. Taxanes seem to impact negatively ovarian function, but data on ovarian reserve are scarce. @entity248 is a predictor of the occurrence of chemotherapy-related @entity2588 and is the most relevant hormonal marker of ovarian reserve. CONCLUSION: Serum @entity248 is a relevant tool for ovarian reserve assessment and follow-up during treatment in premenopausal @entity1 with @entity0 . Further large prospective studies are necessary to determine its predictive interest for post-treatment residual fertility, and eventually use it in fertility preservation counseling before treatment initiation.

Anti-m  llerian hormone levels and evolution in XXXX of reproductive age with @entity0 treated with chemotherapy.

@entity1 :: ('9606', 'Species') :: ['women'] @entity248 :: ('268', 'Gene') :: ['AMH'] @entity0 :: ('MESH:D001943', 'Disease') :: ['Breast cancer', 'breast cancer'] @entity6023 :: ('MESH:D043823', 'Chemical') :: ['taxanes'] @entity5 :: ('MESH:D009369', 'Disease') :: ['malignancy'] @entity2670 :: ('MESH:D010049', 'Disease') :: ['ovarian toxicity', 'ovarian reserve, ovarian function'] @entity2588 :: ('MESH:D000568', 'Disease') :: ['amenorrhea']
@entity1 :: (9606,Species) :: ['women']
